The European Commission has identified 10 strategic economic sectors and domains of public interest in order to boost data-driven innovation and the competitiveness of the European data economy. In the D&I Quarterlies of 2023 we will monitor closely the developments in each data space within the strategic economic sectors in addition to the horizontal data related regulations applicable across economic sectors.
Commission proposes extension of IVDR transition periods for legacy productsThe European Commission has on 23 January 2024 announced a proposal for an extension to the tra...
The Big 5 – Status of National Preparation in FinlandThe so-called Big 5 acts – the Data Governance Act, Digital Markets Act, Digital Services Act...
More by the same author
The European Commission has on 23 January 2024 announced a proposal for an extension to the transition period for the forthcoming In Vitro Diagnostic Medical Devices Regulation (IVDR). The aim is to ensure patient care by improving the availability of these essential healthcare products. In addition, the Commission also proposes measures to enable and accelerate a gradual roll out of EUDAMED, a database that will contain information about all medical devices and in vitro diagnostics (IVDs) placed on the EU market. The mandatory use of finalised parts of EUDAMED will support all key players in the implementation of the regulatory framework and enhance transparency for the public.
The so-called Big 5 acts – the Data Governance Act, Digital Markets Act, Digital Services Act, Data Act, and Artificial Intelligence Act – have been a key part of the European Data Strategy in recent years. Once approved, the Big 5 acts are directly applicable throughout the EU, but many of them require Member States to enact legislation to support their enforcement and supervision, e.g., to designate nationally competent authorities and assign them new powers.
Our life science experts Dr Juli Mansnérus, Charlotta Bonsdorff and Petro Vornanen seized the opportunity to contribute to the intricate field of medical law as they provided their expertise to the Office of the Ombudsman for Children in the form of an article regarding off-label medicine use in children.
A year of big reforms – Review of Finnish merger control in 2023
Alert / 9 Feb 2024
Reading time 6 minutes